The Value of Amniopatch in Preterm Premature Rupture of Membranes

Summary

A randomized controlled trial that involved 100 women diagnosed with PPROM between 24 and 34 weeks of gestational age. Participants were randomized equally into 2 groups. Group I in which amniopatch was done (an amnioinfusion of platelet concentrate followed by fresh frozen plasma in addition to the routine management used in the control group. Group II were treated with routine management including antibiotics and corticosteroids

Timeline

Start

2016-10-01

Primary completion

2017-12-30

Completion

2018-03-11

Drugs

Indications